earnings
confidence high
sentiment positive
materiality 0.75
ADT Q4 revenue +8%, FY GAAP EPS +40%, $500M buyback authorized
ADT Inc.
- Q4 revenue $1,260M (+8%), FY $4,898M (+5%); GAAP EPS $0.21 (Q4), $0.66 (FY), up 91%/40%.
- Adjusted EPS $0.20 (Q4, +11%), $0.75 (FY, +25%); Adj FCF including swaps $744M (+42%).
- Record customer retention: gross revenue attrition 12.7%; RMR $359M (+2%); 16 molecules in clinic.
- Declared $0.055 dividend payable Apr 3; authorized $500M buyback through Apr 2026; redeemed $500M notes, new $600M term loan.
- 2025 guidance: revenue $5,025-$5,225M; Adj EBITDA $2,650-$2,750M; Adj EPS $0.77-$0.85; Adj FCF $800-$900M.